Monographs: Pharmaceutical substances: Levamisole hydrochloride (Levamisoli hydrochloridum)2015-01
C11H12N2S.HCl Relative molecular mass. 240.8 Chemical name. (6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole monohydrochloride; (6S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole hydrochloride (1:1); CAS Reg. No. 16595-80-5. Description. A white or almost white, crystalline powder. Solubility. Freely soluble in water; soluble in ethanol (~750 g/L) TS; slightly soluble in dichloromethane R. Category. Anthelminthic. Storage. Levamisole hydrochloride should be kept in a well-closed container, protected from light. Requirements Levamisole hydrochloride contains not less than 98.5% and not more than 101.0% of C11H12N2S,HCl, calculated with reference to the dried substance. Identity tests
Clarity and colour of solution. A solution of 0.50 g in 10 mL of carbon dioxide-free water R is clear and not more intensely coloured than standard colour Yw1 when compared as described under 1.11.1 Colour of liquids. Sulfated ash. Not more than 1.0 mg/g. Loss on drying. Dry to constant mass at 105 °C; it loses not more than 5.0 mg/g. pH value. pH of a 50 mg/mL solution, 3.0–4.5. Related substances. Prepare fresh solutions and perform the tests without delay. Carry out the test as described under 1.14.1 Chromatography, High-performance liquid chromatography using a stainless steel column (10 cm x 4.6 mm) packed with particles of base-deactivated silica gel, the surface of which has been modified by chemically-bonded octadecylsilyl groups (3 µm). Use the following conditions for gradient elution:
Operate with a flow rate of 1.5 mL per minute. As a detector use an ultraviolet spectrophotometer set at a wavelength of 215 nm. As a dissolution solvent prepare a mixture of 90 volumes of methanol R and 10 volumes of ammonia (~260 g/L) TS. Prepare the following solutions: for solution (1) transfer 100 mg of the test substance to a 10 mL volumetric flask, dissolve in about 6 mL of the dissolution solvent and dilute to volume with the dissolution solvent. For solution (2) dilute 1.0 mL of solution (1) to 100.0 mL with methanol R. For solution (3) dissolve in a test tube 20 mg of the test substance in 5 mL of a 0.1 mol/L solution of sodium hydroxide R. Close and heat the test tube in a boiling water-bath for 5 hours. Allow to cool and dilute 1 mL of the resulting solution to 25 mL with methanol R. For solution (4) transfer 5.0 mL of solution (2) to a 50 mL volumetric flask and dilute to volume with methanol. Inject 10 µL of solution (3). The test is not valid unless the chromatogram shows a peak due to impurity C eluting at the relative retention of about 1.5 with reference to levamisole (retention time about 3.5 minutes). Inject separately 10 µL each of solutions (1) and (4). The chromatogram obtained with solution (1) may show peaks due to the following impurities eluting at the following relative retention with reference to levamisole (retention time about 3.5 minutes): impurity A about 0.9; impurity B about 1.4; impurity C about 1.5; impurity D about 1.6; impurity E about 2.0. In the chromatogram obtained with solution (1):
Heavy metals. Use 1.0 g for the preparation of the test solution as described under 2.2.3 Limit test for heavy metals, use procedure 1 or procedure 3 for the preparation of the test solution; determine the heavy metals content according to method A; not more than 20 μg/g. Assay Dissolve about 0.2 g, accurately weighed, in 30 mL of ethanol (~750 g/L) TS and add 5 mL of hydrochloric acid (0.01 mol/L) VS. Titrate with sodium hydroxide (0.1 mol/L) VS, determining the two inflection points potentiometrically. Record the volume in mL of sodium hydroxide (0.1 mol/L) VS consumed between the two inflection points. Each mL of sodium hydroxide (0.1mol/L) VS is equivalent to 24.08 mg of C11H12N2S,HCl. Impurities A. rac-3-[(2R)-2-amino-2-phenylethyl]-1,3-thiazolidin-2-one, B. 3-[(E)-2-phenylethenyl]thiazolidin-2-imine, C. rac-(4R)-4-phenyl-1-(2-sulfanylethyl)imidazolidin-2-one, D. 6-phenyl-2,3-dihydroimidazo[2,1-b][1,3]thiazole, E. 1,1'-[disulfanediylbis(ethane-2,1-diyl)]bis[(4RS)-4-phenylimidazolidin-2-one].
|